What is he best known for?
The fields of study he is best known for:
- Internal medicine
- Disease
- Surgery
His scientific interests lie mostly in Internal medicine, Surgery, Vasculitis, Polymyalgia rheumatica and Giant cell arteritis.
Internal medicine is frequently linked to Gastroenterology in his study.
The concepts of his Surgery study are interwoven with issues in Infliximab, Incidence and Pediatrics.
His Vasculitis research integrates issues from Systemic disease, Radiology and Vascular disease.
His Polymyalgia rheumatica research includes elements of Synovitis, Bursitis, Tenosynovitis, Prospective cohort study and Giant cell.
His Giant cell arteritis research is multidisciplinary, incorporating elements of Immunology, Clinical trial, Arteritis and Cohort.
His most cited work include:
- Polymyalgia rheumatica and giant-cell arteritis. (1102 citations)
- EULAR Recommendations for the management of primary small and medium vessel vasculitis (717 citations)
- The International Criteria for Behçet's Disease (ICBD): A collaborative study of 27 countries on the sensitivity and specificity of the new criteria (531 citations)
What are the main themes of his work throughout his whole career to date?
His main research concerns Internal medicine, Giant cell arteritis, Vasculitis, Polymyalgia rheumatica and Gastroenterology.
Internal medicine and Surgery are commonly linked in his work.
His work in the fields of Giant cell arteritis, such as Large vessel vasculitis, intersects with other areas such as In patient.
His Vasculitis study integrates concerns from other disciplines, such as Biopsy, Radiology, Vascular disease and Central nervous system.
Carlo Salvarani combines subjects such as Dermatology, Erythrocyte sedimentation rate, Synovitis and Bursitis with his study of Polymyalgia rheumatica.
Carlo Salvarani focuses mostly in the field of Gastroenterology, narrowing it down to topics relating to Immunology and, in certain cases, Allele, Genotype and Behcet's disease.
He most often published in these fields:
- Internal medicine (47.56%)
- Giant cell arteritis (22.59%)
- Vasculitis (20.93%)
What were the highlights of his more recent work (between 2018-2021)?
- Internal medicine (47.56%)
- Tocilizumab (7.02%)
- Giant cell arteritis (22.59%)
In recent papers he was focusing on the following fields of study:
His main research concerns Internal medicine, Tocilizumab, Giant cell arteritis, Gastroenterology and Vasculitis.
His work on Internal medicine deals in particular with Interstitial lung disease, Prednisone, Rheumatology, Cohort and Rheumatoid arthritis.
The study incorporates disciplines such as MEDLINE, Pneumonia, Clinical endpoint, Randomized controlled trial and Placebo in addition to Tocilizumab.
His Giant cell arteritis research is multidisciplinary, incorporating perspectives in Biopsy and Methotrexate.
In his study, Intensive care medicine is inextricably linked to Disease, which falls within the broad field of Gastroenterology.
His Vasculitis research incorporates themes from Arthritis, Eosinophilic and Rituximab.
Between 2018 and 2021, his most popular works were:
- Tocilizumab in patients with severe COVID-19: a retrospective cohort study (389 citations)
- Drug Retention Rate and Predictive Factors of Drug Survival for Interleukin-1 Inhibitors in Systemic Juvenile Idiopathic Arthritis. (313 citations)
- Effect of Tocilizumab vs Standard Care on Clinical Worsening in Patients Hospitalized With COVID-19 Pneumonia: A Randomized Clinical Trial. (166 citations)
In his most recent research, the most cited papers focused on:
- Internal medicine
- Disease
- Surgery
His scientific interests lie mostly in Internal medicine, Tocilizumab, Interstitial lung disease, Giant cell arteritis and Rheumatoid arthritis.
Internal medicine is closely attributed to Gastroenterology in his work.
He interconnects Vasculitis and Dactylitis in the investigation of issues within Gastroenterology.
His Tocilizumab research is multidisciplinary, relying on both Logistic regression, Systematic review, Intensive care medicine, Clinical endpoint and Cohort.
The various areas that Carlo Salvarani examines in his Giant cell arteritis study include Biopsy and Radiology.
The concepts of his Rheumatoid arthritis study are interwoven with issues in Randomized controlled trial, Nintedanib, Idiopathic pulmonary fibrosis, Combination therapy and Disease.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
